Why RTM, RPM, and CCM Represent a Practice Growth Opportunity in 2026 for Pain and Orthopedic Practices Why RTM, RPM, and CCM Represent a Practice Growth Opportunity in 2026 for Pain and Orthopedic Practices In 2026, pain management and orthopedic practices continue to face pressure from utilization controls, site-of-service scrutiny, and reimbursement variability. While procedural care remains central to these specialties, CMS Medicare policy increasingly reflects a broader view of care—one that recognizes the importance of ongoing clinical engagement, monitoring, and coordination beyond episodic visits. Remote Therapeutic Monitoring (RTM), Remote Physiologic Monitoring (RPM), and Chronic Care Management (CCM) are not experimental or temporary Medicare programs. Their continued inclusion and refinement in the Medicare Physician Fee Schedule (PFS) signal CMS’s sustained intent to support longitudinal care models. For practices that understand CMS requirements and operational expectations, these programs represent a practice growth opportunity rooted in care continuity rather than procedure volume. CMS Direction in 2026: Supporting Longitudinal Care CMS Medicare payment policy has steadily evolved to recognize services that extend clinical oversight beyond traditional face-to-face encounters. This direction reflects CMS priorities related to:
The Limits of Procedure-Driven Growth Procedure-based care remains essential in pain and orthopedic practices. However, reliance on procedures alone exposes practices to variability driven by prior authorization requirements, site-of-service policies, and scheduling constraints. CMS-recognized monitoring and care management services provide a complementary pathway that supports patients between procedures and visits while aligning with Medicare payment policy. Why Pain and Orthopedic Practices Are Well Positioned Pain and orthopedic practices routinely manage patients with:
Understanding RTM, RPM, and CCM as CMS Care Programs CMS distinguishes RTM, RPM, and CCM based on what is monitored and how care is managed:
CPT Code Groups and National Fee Schedule Context (CMS Medicare – 2026) Important framing: This section explains CMS-recognized CPT code groups and Medicare requirements, not billing optimization or payer strategy. Remote Therapeutic Monitoring (RTM) — CPT Codes (Medicare 2026) CMS recognizes RTM through CPT code families that include device setup, data transmission, and treatment management. RTM CPT code group:
Remote Physiologic Monitoring (RPM) — CPT Codes (Medicare 2026) CMS expanded RPM flexibility in 2026 to reflect real-world monitoring patterns. RPM CPT code group:
Chronic Care Management (CCM) — CPT Codes (Medicare 2026) CMS continues to support CCM as a structured care coordination service for patients with multiple chronic conditions. Common CCM CPT codes:
Documentation and Time Discipline Under CMS Rules Across RTM, RPM, and CCM, CMS emphasizes:
Practice Growth Without Increasing Procedure Volume When implemented in alignment with CMS intent, RTM, RPM, and CCM allow practices to:
Operational Design Matters CMS-recognized monitoring and care management services require:
Aligning Opportunity With Compliance CMS Medicare rules apply specifically to Medicare beneficiaries and should not be assumed to apply identically to other payers. Practices that clearly separate Medicare compliance frameworks reduce audit risk and protect long-term sustainability. Takeaways: RTM, RPM, and CCM represent CMS-supported pathways for extending care beyond traditional encounters. Their continued recognition in the Medicare Physician Fee Schedule signals CMS’s long-term intent to support longitudinal care models. For pain and orthopedic practices, these programs offer an opportunity to support continuity of care and operational stability—without increasing procedure volume or compromising compliance. CMS Excerpt Appendix:
References & CMS URLs
About the Author:
Pinky Maniri Pescasio is a healthcare operations and reimbursement consultant with more than two decades of experience supporting U.S. medical practices, with a focus on pain management and orthopedic specialties. She is the Founder and CEO of GoHealthcare Practice Solutions, where she advises practices on CMS Medicare policy interpretation, reimbursement frameworks, and operational alignment across care delivery models.
0 Comments
Prior Authorization in 2026: What Every Specialty Practice Must Know About the New Rules and AI Automation Prior authorization remains one of the most challenging administrative burdens in healthcare. It affects every specialty practice in the United States and continues to create delays, patient frustration, denials, and preventable financial loss. Primary care, cardiology, neurology, orthopedics, pain management, gastroenterology, pulmonology, endocrinology, OBGYN, behavioral health, pediatrics, urology, dermatology, and surgical specialties all rely on accurate prior authorization workflows to ensure patients receive timely care and providers receive timely reimbursement. In 2026, new federal rules, payer requirements, and technological advancements are reshaping the prior authorization landscape. Artificial intelligence is now becoming essential for managing complex documentation, predicting requirements, and reducing administrative burden. This article outlines the most important changes every specialty must understand and how AI is transforming the process. The 2026 Regulatory Shift in Prior Authorization The Centers for Medicare and Medicaid Services introduced reforms focused on improving transparency, reducing care delays, and encouraging automation. These rules impact both payers and providers. Key federal updates include:
Why Prior Authorization Has Become More Difficult for All Specialties Every specialty faces unique prior authorization demands. Payers continue to expand requirements across imaging, procedures, medications, and testing. The volume of authorization requests has increased dramatically, and each payer uses different rules, clinical guidelines, and documentation formats. Common challenges include:
How AI Improves Prior Authorization Accuracy and Workflow AI technology helps providers streamline prior authorization. By analyzing payer requirements, clinical criteria, and historical denial patterns, AI tools provide clear recommendations and reduce manual work. AI improves prior authorization by:
Specialty-Specific Prior Authorization Challenges Solved by AI Primary Care: AI confirms requirements for imaging, diagnostic testing, and specialty referrals. Cardiology: AI identifies authorization criteria for echocardiograms, stress tests, and advanced imaging. Neurology: AI supports prior authorization for EEG, EMG, MRI, and neuromodulation procedures. Orthopedics and Sports Medicine: AI detects requirements for therapy, injections, imaging, and surgical procedures. Pain Management: AI helps verify authorization for spinal injections, RF ablation, and advanced interventions. Gastroenterology: AI identifies rules for colonoscopy, endoscopy, and diagnostic testing. OBGYN AI verifies maternity-related procedures and imaging approvals. Pulmonology: AI supports authorization for CT, sleep studies, and pulmonary function tests. Behavioral Health: AI validates mental health service approvals and identifies plan limitations. Endocrinology: AI evaluates prior authorization for specialty medications and diagnostic testing. Pediatrics: AI supports complex benefit checks for children with multiple coverage sources. Across all specialties, AI reduces manual effort and helps ensure timely authorization. The Relationship Between Prior Authorization and Denial Prevention Prior authorization errors lead to significant denials. Denials occur when:
How AI Supports Compliance and Audit Readiness AI not only improves accuracy but also strengthens compliance. Payers and CMS expect providers to meet documentation requirements. AI supports this by:
The Future of Prior Authorization in 2026 and Beyond Prior authorization will continue evolving with stronger emphasis on automation. AI will play a central role in:
Key Points for Healthcare Leaders
About the Author: Pinky Maniri Pescasio is the Founder and Chief Executive Officer of GoHealthcare Practice Solutions, Vaydah Healthcare, and Axendra Solutions. She is a national leader in revenue cycle management, healthcare operations, medical practice consulting, global nurse workforce strategy, and AI enabled workflow transformation. With 30 years of experience supporting specialty practices across the United States, Pinky is recognized for her expertise in coding, compliance, prior authorization, audit prevention, and CMS regulatory navigation. She is certified in Healthcare AI Governance, bringing executive level insight into how artificial intelligence strengthens operational efficiency, revenue integrity, and compliance across clinical and administrative workflows. Through her companies, Pinky helps physicians, medical groups, and ambulatory surgery centers improve cash flow, reduce denials, optimize operations, and navigate regulatory complexity with clarity and precision. Learn more about her leadership background at https://www.gohealthcarellc.com/leadership.html How Site of Service and Prior Authorization Affect Payment in 2026 for Pain and Orthopedic Practices2/3/2026 How Site of Service and Prior Authorization Affect Payment in 2026 for Pain and Orthopedic Practices In 2026, payment outcomes for pain management and orthopedic practices are increasingly shaped before a claim is ever submitted. Even when medical necessity is met and prior authorization is obtained, reimbursement can still be reduced, delayed, or adjusted if the authorized site of service does not align with where care is ultimately delivered. This dynamic is not driven by a single regulation. Instead, it reflects how coverage policy, prior authorization workflows, and payment adjudication operate as separate but intersecting systems across Medicare, Medicare Advantage, and commercial payers. Understanding where these systems diverge is essential for practices that deliver care across physician offices, ambulatory surgery centers (ASCs), and hospital outpatient departments (HOPDs). The Centers for Medicare & Medicaid Services (CMS) establishes the foundational coverage and payment framework for Medicare fee-for-service. Medicare Advantage plans and commercial payers then apply their own utilization management and site-of-service rules on top of that framework. In 2026, the consequences of misalignment between these layers are increasingly visible in payment outcomes. CMS as the Baseline, Not the Only Payer CMS does not rely on prior authorization for most physician services under traditional Medicare. Instead, CMS enforces payment policy through coverage determinations, documentation requirements, and post-payment review. Under this model:
In 2026, CMS guidance continues to influence payer behavior indirectly by reinforcing setting-based payment differences and outpatient eligibility. However, CMS does not guarantee payment outcomes when authorization workflows are administered by non–fee-for-service payers. How Medicare Advantage Applies CMS Logic Medicare Advantage plans must provide Medicare-covered benefits, but may apply plan-specific utilization management, including prior authorization, within CMS requirements. As a result, Medicare Advantage plans frequently:
Commercial Payers and Site-of-Service Programs Commercial payers increasingly use site-of-service programs to manage costs by steering care toward lower-cost settings. These programs operate independently of CMS, but often mirror similar payment logic. In 2026, commercial payer site-of-service programs commonly include:
Why Prior Authorization Creates False Security One of the most common misconceptions in outpatient procedural care is that prior authorization guarantees payment. In practice, authorization typically confirms only that a payer has approved a service under defined conditions. Authorizations commonly specify:
In 2026, authorization complexity increases the likelihood that:
Where Misalignment Happens Before Billing Misalignment typically occurs during routine operational handoffs rather than billing errors. Common points of breakdown include: Scheduling Changes Procedures may be moved to accommodate availability, equipment, or patient needs. When the site changes, authorization alignment may not be reassessed. Facility vs Non-Facility Drift Services initially planned for office settings may be performed in ASCs or HOPDs due to clinical considerations, while authorization remains tied to the original setting. Documentation Mismatch Medical records may support the procedure but fail to reconcile differences between the authorized and rendered site of service. Operational Hand-Offs Authorization teams, schedulers, and clinical staff often operate independently, allowing misalignment to go unnoticed until payment adjudication. These breakdowns occur before billing, yet directly affect reimbursement. How Payment Is Affected Without Denials Misalignment does not always result in immediate denials. In 2026, practices may experience more subtle payment impacts, including:
Because claims may still be processed, these impacts can be difficult to detect and may appear as unexplained revenue variance rather than denials. Operational Implications for Pain and Orthopedic Practices The consequences of misalignment are operational rather than clinical. CMS does not require changes to patient care, but it does require consistency between what is authorized, what is documented, and what is billed. In 2026, practices benefit from:
Takeaways: In 2026, payment outcomes for pain management and orthopedic practices are increasingly determined before claims submission. Misalignment between site of service and prior authorization can affect reimbursement across Medicare, Medicare Advantage, and commercial payers. Prior authorization alone does not guarantee payment. Consistent alignment between authorized settings, rendered services, and documentation is essential to maintaining reimbursement stability. Understanding where misalignment occurs allows practices to address revenue risk proactively without altering clinical care. Framework Sources
About the Author:
Pinky Maniri Pescasio is a healthcare operations and reimbursement consultant with more than two decades of experience working with U.S. medical practices, with a specialized focus on pain management and orthopedic specialties. She is the Founder and CEO of GoHealthcare Practice Solutions, where she advises physician practices, ambulatory surgery centers, and healthcare organizations on Medicare policy interpretation, payer reimbursement frameworks, and operational risk related to coverage, authorization, and payment alignment. Her work centers on translating CMS guidance and payer policy into practical operational insight, particularly where site of service, prior authorization, and documentation intersect. Pinky is known for her disciplined, accuracy-first approach to healthcare policy analysis and for helping practices understand how payment systems function in real-world settings without overstating regulatory intent or creating unnecessary compliance exposure. How AI Is Eliminating Eligibility Errors for All Specialty Practices and Protecting the Revenue Cycle Eligibility and benefits verification continue to be one of the most important steps in the revenue cycle. It is also one of the most vulnerable. Across every specialty in the United States, practices lose revenue because eligibility information is incomplete, outdated, or misinterpreted. This affects primary care, cardiology, neurology, pain management, orthopedics, OBGYN, gastroenterology, pulmonology, behavioral health, pediatrics, endocrinology, surgery, urology, dermatology, and multi-specialty groups. The financial impact touches practices of every size and structure, from outpatient clinics to integrated health systems. As healthcare moves into 2026 with greater complexity, more payer variation, and increasing patient responsibility, eligibility verification must evolve. Artificial intelligence is now becoming one of the most reliable ways to reduce preventable denials and support a stronger financial foundation for all practices. This article provides a comprehensive overview of how AI is transforming eligibility verification, why the change is necessary, and what healthcare leaders must understand to protect their revenue and improve patient financial clarity. The Growing Financial Impact of Eligibility Errors: Eligibility-related denials remain one of the top contributors to revenue leakage. These denials are considered preventable because they originate from data that should have been validated before the patient encounter. The Centers for Medicare and Medicaid Services consistently reports that incorrect eligibility information contributes to billing inaccuracies and improper claim submission. Common issues include:
Why Traditional Eligibility Verification No Longer Works for Modern Practices: Traditional verification methods require staff to:
Manual errors are inevitable because:
How AI Transforms Eligibility Verification for All Specialties: Artificial intelligence introduces consistency and accuracy at a level that manual processes cannot match. AI powered eligibility systems extract, interpret, and validate payer data with speed and accuracy. This reduces administrative burden and prevents revenue leakage. AI brings several key advantages:
Eligibility Challenges Unique to Different Specialties: Although eligibility verification affects every specialty, the challenges vary. AI supports these variations by analyzing benefit details that matter most to each field. Primary Care: High patient volume and frequent plan changes require automated verification to maintain accuracy. Cardiology and Neurology: AI identifies diagnostic imaging restrictions and specialty procedure requirements. Orthopedics and Sports Medicine: AI confirms benefits for injections, therapy, imaging, and surgical procedures. Pain Management: AI validates coverage for spinal procedures, injections, and ablative therapies. Gastroenterology: AI checks screening eligibility, diagnostic benefits, and imaging limitations. OBGYN: AI identifies maternity-related coverage and benefit limitations. Pulmonology: AI confirms eligibility for diagnostic testing and high cost imaging. Endocrinology: AI reviews specialty testing coverage and medical necessity requirements. Behavioral Health: AI validates mental health benefits and identifies common exclusions. Pediatrics: AI identifies coordination of benefits issues and specialty referral requirements. AI adapts to the needs of each specialty by identifying patterns and coverage details that matter most for accurate billing and financial transparency. The Financial Link Between AI and Patient Clarity: Strong eligibility verification improves patient satisfaction and reduces financial confusion. AI ensures accuracy in:
This creates:
AI strengthens communication with patients and supports revenue cycle predictability. AI and Compliance Protection for Every Specialty: Eligibility errors create compliance risk. CMS and commercial payers expect providers to verify coverage before procedures are performed. AI strengthens compliance by:
How AI Improves Practice Management and Staff Efficiency AI reduces the administrative burden for front desk teams by eliminating many of the repetitive tasks that consume time and create burnout. Teams gain:
The Future of Eligibility Verification Across All Specialties Eligibility verification is evolving rapidly. AI will continue to shape this space by:
Key Points for Healthcare Leaders
About the Author: Pinky Maniri Pescasio is the Founder and Chief Executive Officer of GoHealthcare Practice Solutions, a national leader in revenue cycle management, AI enabled operations, and medical practice consulting. With nearly thirty years of experience supporting specialty practices across the United States, she is recognized for her expertise in coding, compliance, prior authorization, audit prevention, and CMS regulatory navigation. Pinky helps physicians and medical groups strengthen cash flow, reduce denials, and modernize their operations through AI driven workflows and evidence based RCM strategies. She is a certified specialist in AI Fundamentals and Healthcare AI Governance, and a trusted advisor to providers in both clinic and ASC settings. The Blueprint for Prior Authorization in Interventional Pain Management: 2026 Edition The Blueprint for Prior Authorization in Interventional Pain Management: 2026 Edition Prior authorization remains one of the most significant administrative and financial barriers facing interventional pain management practices in 2026. As CMS, commercial payers, and prior authorization management companies tighten utilization controls, specialty practices must evolve from reactive workflows to evidence-driven, policy-aligned, audit-resistant systems. This blueprint outlines the 2026 regulatory environment, payer expectations, and operational playbooks needed to protect revenue, reduce denials, and maintain compliance for high-volume pain practices. It is designed for practice administrators, physicians, MSO leaders, and compliance teams responsible for building scalable, high-accuracy prior authorization operations. 1. The 2026 Prior Authorization Landscape Interventional pain management continues to be one of the highest-scrutinized specialties in U.S. healthcare. Payers—including Medicare Advantage, commercial insurers, and delegated UM companies—have identified several procedure categories as "high utilization” or “high risk.” These include:
For many practices, the barrier is no longer a medical necessity it’s documentation precision and operational workflow. 2. Why Prior Authorization Fails in Pain Practices Based on 20+ years of consulting for national specialty groups, the major failure points include: 1. Inconsistent documentation Providers document findings, but not in the exact sequence or specificity that payers require. 2. Missing elements from LCDs or payer guidelines This includes failure to indicate failed conservative management, radicular symptoms, or functional impairment. 3. No structured intake process Front desk and call centers lack triage scripts that capture payer-required information before authorization submission. 4. Untrained or overwhelmed staff Authorizations are often handled by staff unfamiliar with pain-specific clinical criteria. 5. No quality assurance Practices rarely audit their own PA submissions, leading to preventable denials. 6. Delayed submissions Procedures get scheduled before the authorization is fully approved. 7. Lack of payer-specific templates One-size documentation does NOT work. 8. No use of EHR-driven automation Many practices still fax or manually upload clinicals instead of integrating clean workflows. 3. What Payers Require in 2026 (Across All Carriers) No matter the insurance, payers look for the same foundation: A. Clear Diagnosis Alignment The ICD-10 code must match the CPT code’s medical necessity. B. Objective Clinical Findings This includes:
Most carriers require:
Usually, 6 weeks minimum unless red flags exist. E. Procedure Justification That Mirrors LCD or Policy Language This is the most important factor in 2026. Authorizations are not simply approved because a physician requested them; they are approved because the documentation mirrors the exact language in the payer’s own criteria. 4. The 2026 PA Blueprint for Pain Practices Below is the operational model top-performing practices use to achieve a 95–98% approval rate. STEP 1: Intake & Triage (Front Desk + Call Center) Your team collects:
STEP 2: Clinical Documentation Template (Physician) Every pain physician should use a structured note that includes: 1. Objective exam findings 2. Functional impairment 3. Imaging findings with dates 4. Failed conservative management 5. Previous interventions 6. Medical necessity tied to LCD or payer policy language When documentation is structured, authorization approvals increase dramatically. STEP 3: The Prior Authorization Submission Process Payers want:
A. Carrier-specific checklists Every payer has differences. We build custom checklists for each plan. B. Standardized naming conventions Clean uploads → faster approvals. C. Submission tracking Authorizations must be logged with:
STEP 4: Denial Prevention Rules Top-performing pain practices use:
STEP 5: Appeals & Peer-to-Peers A strong appeals process includes:
5. Financial Impact: Why This Blueprint Matters A denied or delayed authorization creates:
In 2026, pain practices with weak processes risk losing 6–15% of total annual revenue due to PA friction. But practices using systemized prior authorization workflows recover:
6. Building an Audit-Resistant Authorization Department CMS and commercial plans are increasing prior authorization audits in:
Your PA department must operate like a clinical compliance unit, not just admin support. Best-in-class includes:
Key Takeaways
References Centers for Medicare & Medicaid Services (CMS) – Program Integrity https://www.cms.gov/program-integrity CMS Medicare Physician Fee Schedule https://www.cms.gov/medicarephysicianfeeschedule AMA CPT Editorial Panel https://www.ama-assn.org/practice-management/cpt OIG Work Plan https://oig.hhs.gov/reports-and-publications/workplan AHRQ Evidence-Based Practice https://www.ahrq.gov About the Author: Pinky Maniri Pescasio is a national speaker, healthcare operations strategist, and founder of GoHealthcare Practice Solutions, GoHealthcare AI Solutions, Axendra Solutions, and Vaydah Healthcare. With nearly 30 years of experience in revenue cycle leadership, AI governance, prior authorization strategy, and specialty practice optimization, she is recognized as a leading expert across pain management, orthopedic, spine, and multispecialty practice operations. For speaking engagements or advisory inquiries, visit: www.gohealthcarellc.com Why Medical Necessity Matters Under CMS Guidance in 2026 for Pain and Orthopedic Procedures1/27/2026 Why Medical Necessity Matters Under CMS Guidance in 2026 for Pain and Orthopedic Procedures Calendar Year (CY) 2026 Medicare payment policy reinforces a principle that has always existed but is increasingly consequential in practice: medical necessity is a prerequisite to payment, not a byproduct of coding accuracy. For pain management and orthopedic procedures, CMS guidance makes clear that reimbursement is contingent not only on what service is performed, but on whether the medical record demonstrates that the service was reasonable and necessary under applicable coverage standards. The Centers for Medicare & Medicaid Services (CMS) does not issue a single, consolidated “medical necessity rule.” Instead, medical necessity is operationalized across multiple policy layers, including the Physician Fee Schedule (PFS), National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), and Medicare Benefit Policy Manual provisions. In 2026, these layers continue to function together as a payment gatekeeping framework, particularly for high-utilization procedural specialties such as pain management and orthopedics. This article examines how CMS applies medical necessity under 2026 guidance and why it remains a central determinant of payment for pain and orthopedic procedures. How CMS Applies Medical Necessity in 2026 CMS consistently distinguishes between coverage, coding, and payment. A service may be correctly coded and submitted, yet still unpaid if CMS determines that the service does not meet medical necessity requirements under applicable coverage policy. In 2026, CMS continues to rely on:
CMS guidance does not redefine medical necessity for 2026. Instead, it reinforces existing policy expectations by integrating them more tightly into claims processing, medical review, and post-payment analysis. Medical Necessity as a Condition of Payment, Not Coding A persistent source of reimbursement disruption in pain and orthopedic practices is the assumption that correct CPT coding equates to payable services. CMS policy makes clear that this is not the case. Under Medicare:
In 2026, CMS continues to apply automated and manual review processes that evaluate documentation against LCD and NCD requirements, even when claims are otherwise clean. This distinction explains why practices may experience:
These outcomes reflect CMS’s separation of technical correctness from coverage justification. Medical Necessity in Pain Management Procedures Pain management services are among the most heavily governed by LCDs due to utilization patterns and procedural complexity. CMS relies extensively on MAC-issued LCDs to enforce medical necessity for interventional pain procedures. In 2026, CMS policy continues to emphasize several recurring medical necessity themes in pain management: Conservative Treatment Requirements LCDs commonly require documentation of failed or inadequate conservative therapy before interventional procedures are considered reasonable and necessary. CMS does not prescribe a universal definition of conservative care, but LCDs typically specify:
Diagnostic vs Therapeutic Intent CMS coverage policy distinguishes between diagnostic procedures and therapeutic interventions. Medical necessity depends on whether:
Inconsistent documentation of intent can undermine medical necessity even when procedures are otherwise appropriate. Frequency and Progression CMS guidance through LCDs often establishes frequency limitations and expectations for procedural progression. In 2026, CMS continues to rely on these parameters to evaluate whether services represent reasonable clinical escalation rather than repetitive utilization. Documentation that fails to demonstrate clinical rationale for repeated procedures may result in payment adjustments even if frequency thresholds are not explicitly exceeded. Consistency Across Episodes of Care CMS evaluates medical necessity longitudinally. Inconsistent documentation across visits, procedures, and follow-up care can weaken medical necessity determinations. In 2026, CMS continues to emphasize record consistency as part of medical review, particularly for procedural pain services delivered over time. Medical Necessity in Orthopedic Procedures Orthopedic procedures often involve complex decision-making across imaging, conservative management, and surgical intervention. CMS coverage policy evaluates medical necessity in orthopedics by examining the entire care pathway, not isolated services. Key areas of focus under CMS guidance include: Imaging and Diagnostic Support CMS policy expects that imaging and diagnostic studies support the clinical decision to proceed with procedural intervention. Documentation must clearly connect diagnostic findings to the proposed service. Imaging alone does not establish medical necessity. The record must explain how findings correlate with symptoms and functional impairment. Conservative Care Thresholds As in pain management, orthopedic LCDs frequently require documentation of conservative care prior to procedural escalation. CMS does not mandate identical thresholds across all jurisdictions, but consistency with local LCD criteria is required. In 2026, CMS continues to defer to MACs on defining conservative care requirements, reinforcing the importance of jurisdiction-specific compliance. Procedural Escalation Logic CMS evaluates whether the progression from non-operative to operative intervention is supported by the medical record. Documentation should demonstrate:
The Role of LCDs in 2026 While NCDs establish national policy, LCDs remain the primary enforcement mechanism for medical necessity in pain and orthopedic procedures. CMS continues to allow MACs discretion in developing LCDs based on local utilization patterns and clinical evidence. In 2026:
Medical Necessity and Prior AuthorizationCMS distinguishes between prior authorization approval and medical necessity determination. Authorization indicates payer approval to proceed but does not supersede CMS medical necessity standards. In 2026, CMS policy continues to support post-payment review of services that were authorized but later determined not to meet coverage criteria. This distinction is particularly relevant for pain and orthopedic practices, where:
How Medical Necessity Affects Payment Without Denials Medical necessity enforcement does not always result in claim denials. CMS policy allows for payment adjustment mechanisms that operate without initial rejection. In 2026, practices may encounter:
Operational Consequences for Pain and Orthopedic Practices CMS’s 2026 guidance does not introduce new documentation formats or reporting requirements. Instead, it reinforces the need for operational alignment across clinical, administrative, and billing functions. Practices should ensure that:
Compliance Considerations Without Overstatement CMS does not designate medical necessity alone as an audit trigger. However, medical necessity deficiencies frequently surface during medical review activities. In 2026, CMS continues to rely on:
Practices with inconsistent documentation or repeated coverage issues may experience increased scrutiny over time. Takeaways: CMS’s CY 2026 guidance reinforces that medical necessity remains central to Medicare payment for pain management and orthopedic procedures. Through NCDs, LCDs, and payment system integration, CMS continues to evaluate whether services are reasonable and necessary based on documented clinical justification. For pain and orthopedic practices, aligning documentation, authorization, and clinical workflows with CMS coverage expectations is essential to maintaining reimbursement stability. Coding accuracy alone is insufficient when medical necessity is not clearly demonstrated in the medical record. CMS Source Framework
CMS Excerpt Appendix(CY 2026 – Medical Necessity) Source Authority: Centers for Medicare & Medicaid Services The excerpts below are brief quotations or near-verbatim language taken from CMS regulations, manuals, and final rule summaries. They are presented without interpretation. 1. Medical Necessity as a Condition of Payment “Medicare covers services that are reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.” “No payment may be made under Medicare Part B for items or services that are not reasonable and necessary.” 2. Coverage Determinations and Medical Necessity “National Coverage Determinations (NCDs) describe whether specific medical items, services, treatment procedures, or technologies are covered under Medicare.” “Local Coverage Determinations (LCDs) describe coverage within a specific jurisdiction and define medical necessity requirements for services not addressed by an NCD.” 3. Documentation and Medical Review “The medical record must contain sufficient documentation to support the medical necessity of the service billed.” “Coverage decisions are based on the documentation submitted and must demonstrate that the service meets applicable coverage criteria.” 4. Medical Necessity and Payment Outcomes “Correct coding does not ensure coverage or payment if the medical necessity requirements are not met.” “Services that do not meet coverage criteria may be subject to payment reduction or recoupment following medical review.” 5. Physician Fee Schedule and Medical Necessity “Payment under the Physician Fee Schedule is made only for services that are covered and reasonable and necessary under applicable Medicare coverage policies.” 6. Local Coverage Determinations and Contractor Discretion “Medicare Administrative Contractors may develop Local Coverage Determinations to address medical necessity, utilization, and documentation requirements for services.” “Providers are responsible for complying with LCDs applicable to their jurisdiction.” References and Source Documents 1. Medicare Benefit Policy Manual (Medical Necessity Standard) CMS Publication 100-02, Medicare Benefit Policy Manual https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/bp102c15.pdf Key reference for:
2. CMS National Coverage Determinations (NCDs) CMS National Coverage Determination Database https://www.cms.gov/medicare-coverage-database/search.aspx?NCDId=-1&bc=AgAAgAAAAAAAAA%3d%3d& Authoritative source for:
3. CMS Local Coverage Determinations (LCDs) CMS Medicare Coverage Database – LCD Search https://www.cms.gov/medicare-coverage-database/search.aspx Primary enforcement source for:
4. CY 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) CMS Fact Sheet – CY 2026 PFS Final Rule https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-medicare-physician-fee-schedule-final-rule-cms-1832-f Federal Register – Official Rule Text https://www.federalregister.gov/documents/2025/11/05/2025-19787/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other-changes 5. Medicare Claims Processing Manual (Documentation & Review) CMS Publication 100-04, Medicare Claims Processing Manual https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c12.pdf Relevant to:
6. CMS Program Integrity Manual CMS Publication 100-08, Program Integrity Manual https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/pim83c03.pdf Used for:
ABOUT THE AUTHOR:
Pinky Maniri Pescasio is a healthcare operations and reimbursement consultant with more than two decades of experience supporting U.S. medical practices, with a primary focus on pain management and orthopedic specialties. She is the Founder and CEO of GoHealthcare Practice Solutions, where she advises physician practices and outpatient facilities on Medicare payment policy, medical necessity alignment, revenue cycle integrity, and compliance risk management. Her work centers on interpreting and operationalizing CMS coverage and payment guidance, including the Physician Fee Schedule, National and Local Coverage Determinations, and Medicare documentation requirements. She is known for translating complex CMS policy into practical operational considerations without overstating regulatory intent or introducing unnecessary compliance risk. Why Place of Service Matters Under CMS Guidance in 2026 for Pain and Orthopedic Practices Calendar Year (CY) 2026 Medicare payment policies finalized by the Centers for Medicare & Medicaid Services (CMS) reinforce a consistent theme across outpatient and professional payment systems: the setting in which care is furnished is inseparable from how that care is paid. For pain management and orthopedic practices operating across physician offices, ambulatory surgery centers (ASCs), and hospital outpatient departments (HOPDs), CMS’s 2026 guidance makes site-of-service alignment a practical requirement for reimbursement accuracy and compliance stability. CMS does not publish a single “place of service framework.” Instead, site-of-service policy emerges through coordinated changes across the Physician Fee Schedule (PFS), the Outpatient Prospective Payment System (OPPS), and the ASC payment system. In 2026, these changes collectively affect outpatient migration, setting-based payment differentials, and how Medicare evaluates cost structure across care environments. This article consolidates the relevant CMS 2026 policy signals and explains their implications for pain management and orthopedic practices without redefining basic billing concepts or overstating CMS intent. CMS’s 2026 Policy Context for Site of Service CMS’s approach to site of service in 2026 reflects a continuation of long-standing payment principles rather than a departure from them. Medicare payment systems have historically distinguished between services furnished in non-facility settings (such as physician offices) and facility settings (such as HOPDs and ASCs). What changes in 2026 is the degree to which CMS operationalizes that distinction across outpatient systems. Across its final rules, CMS repeatedly emphasizes that:
How CMS Uses Payment Systems to Apply Site-of-Service Logic CMS applies site-of-service policy indirectly, through payment system design rather than explicit mandates. Under the Physician Fee Schedule, professional reimbursement differs depending on whether services are furnished in a facility or non-facility setting. In facility settings, CMS assumes that certain practice expenses are borne by the facility and therefore reimburses the professional component differently than in office-based care. Under OPPS and ASC payment systems, CMS reimburses facilities separately for outpatient services and adjusts payment rates based on statutory authority, cost reporting, and policy objectives. These systems increasingly intersect with PFS logic, particularly where CMS applies site-neutral methodologies. In 2026, CMS continues to align these systems to reinforce setting-based distinctions rather than blur them. Expansion of Site-Neutral Payment in Off-Campus Provider-Based Departments One of the clearest site-of-service signals in CY 2026 appears in the OPPS/ASC final rule, where CMS finalized expansion of its site-neutral payment methodology to include drug administration services furnished in excepted off-campus provider-based departments (PBDs). CMS applies a Physician Fee Schedule–equivalent payment rate for these services when provided in those settings. This policy builds on CMS’s prior application of site-neutral payment to clinic visits in off-campus PBDs. While drug administration services are the specific focus of the 2026 expansion, the policy logic extends beyond those codes. CMS is reinforcing its position that organizational ownership of an outpatient department does not, by itself, justify higher payment when comparable services can be delivered in lower-cost environments. For pain and orthopedic practices, the relevance lies not in the specific services affected, but in how this policy influences:
Practices operating within or alongside provider-based outpatient structures should view this expansion as confirmation that CMS will continue to evaluate outpatient payment through a site-neutral lens where statutory authority permits. Phase-Out of the Inpatient Only (IPO) List Beginning in 2026CMS finalized the first phase of a three-year phase-out of the Inpatient Only (IPO) list, beginning in CY 2026 with the removal of 285 procedures, the majority of which are musculoskeletal. CMS states that advances in medical practice allow many of these procedures to be performed safely in outpatient settings and that removal from the IPO list permits Medicare payment in hospital outpatient settings when clinically appropriate. CMS frames this change as expanding flexibility rather than mandating outpatient migration. For orthopedic practices, this policy materially changes outpatient eligibility. Procedures that were previously restricted to inpatient payment pathways may now be reimbursed in outpatient environments, subject to clinical appropriateness and payer requirements. For pain management practices, the IPO phase-out matters indirectly. As orthopedic procedures migrate outpatient, interventional pain services often intersect with perioperative and post-procedural care pathways. This increases the importance of coordination across settings and reinforces the need for consistent site-of-service planning. ASC Covered Procedures List Revisions CMS finalized revisions to ASC Covered Procedures List (CPL) criteria in CY 2026, eliminating several general exclusion criteria and reclassifying them as nonbinding physician considerations related to patient safety. As a result, CMS added hundreds of procedures and codes to the ASC CPL, including procedures removed from the IPO list. These changes expand the scope of outpatient surgical services eligible for ASC reimbursement under Medicare policy. However, CMS does not eliminate payer discretion or override commercial contract requirements. The practical effect is that ASC eligibility expands under Medicare, while operational complexity remains. For pain management and orthopedic practices with ASC exposure, these revisions increase the importance of:
Non-Opioid Pain Relief Payment Policies in Outpatient Settings CMS finalized continuation of statutory temporary additional payments for certain non-opioid treatments for pain relief furnished in HOPD and ASC settings through December 31, 2027. CMS also finalized the list of qualifying drugs and devices that will be paid separately in both settings beginning in CY 2026. This policy applies specifically to qualifying products identified by CMS and is tied to both product eligibility and outpatient setting. The payment framework is setting-dependent, reinforcing that reimbursement outcomes for pain-related therapies can vary based on where care is delivered. For pain management practices that furnish qualifying therapies, the policy highlights the need for:
This is a targeted policy, but it illustrates CMS’s broader use of outpatient payment systems to shape care delivery and reimbursement patterns. Practice Expense Methodology Changes Under the CY 2026 PFS Under the CY 2026 Physician Fee Schedule, CMS finalized updates to practice expense (PE) methodology that recognize differences in indirect costs between office-based and facility-based settings. CMS states that allocating indirect costs at the same rate across settings may no longer reflect contemporary clinical practice patterns. This change affects how CMS values professional services depending on where they are furnished. For practices that deliver services across multiple settings, changes in PE allocation can shift relative reimbursement without any change to CPT coding or clinical documentation. For pain management and orthopedic practices operating hybrid models, this reinforces that:
How CMS Policy Shapes Payer Behavior Although CMS policy applies directly to Medicare fee-for-service, it often influences payer behavior more broadly. Medicare Advantage plans and commercial payers frequently reference Medicare payment logic when developing site-of-service programs, utilization management rules, and reimbursement differentials. CMS’s 2026 policies provide payers with:
Operational Consequences for Pain Management and Orthopedic Practices CMS’s 2026 guidance does not require new billing codes or documentation formats. Instead, it increases the operational importance of consistency across clinical, administrative, and billing workflows. Practices should expect that:
Compliance Considerations Without Overstatement CMS does not identify site-of-service selection as a standalone audit trigger. However, CMS’s payment methodologies and payer extrapolation of those methodologies mean that inconsistent alignment between care setting, authorization, and billing increases exposure to payment review and post-payment adjustment. The risk is not inherent to any particular setting, but to misalignment between:
Takeaways: CMS’s CY 2026 payment policies reinforce a clear principle: the outpatient care setting matters to how services are paid. Through expansion of site-neutral payment approaches, outpatient migration of musculoskeletal procedures, ASC eligibility revisions, continuation of non-opioid pain relief payment policies, and updates to practice expense methodology, CMS continues to align reimbursement with care setting. For pain management and orthopedic practices, this requires intentional site-of-service planning across clinical, administrative, and billing workflows. Aligning these elements supports reimbursement accuracy and reduces operational disruption under current CMS policy. Source: Centers for Medicare & Medicaid Services All excerpts below are taken from CMS CY 2026 final rule fact sheets, Federal Register summaries, or CMS implementation guidance. Excerpts are intentionally brief to preserve accuracy and context. 1. Site-Neutral Payment in Off-Campus Provider-Based Departments “CMS finalized its proposal to expand the site-neutral payment policy to include drug administration services furnished in excepted off-campus provider-based departments.” “For these services, CMS applies a Physician Fee Schedule equivalent payment rate when furnished in an excepted off-campus PBD.” 2. Phase-Out of the Inpatient Only (IPO) List “CMS is finalizing a three-year phase-out of the Inpatient Only (IPO) list, beginning in CY 2026.” “For CY 2026, CMS finalized removal of 285 procedures, the majority of which are musculoskeletal, from the IPO list.” “Removal from the IPO list allows Medicare payment for these services in the hospital outpatient setting when clinically appropriate.” 3. ASC Covered Procedures List (CPL) Revisions “CMS finalized its proposal to revise the ASC Covered Procedures List criteria.” “CMS eliminated several general exclusion criteria and reclassified them as nonbinding physician considerations for patient safety.” “As a result of these changes, CMS added hundreds of procedures and codes to the ASC Covered Procedures List, including codes removed from the IPO list.” 4. Non-Opioid Pain Relief Payment Policies “CMS finalized its proposal to continue temporary additional payments for certain non-opioid treatments for pain relief furnished in the HOPD and ASC settings through December 31, 2027.” “CMS finalized the list of qualifying drugs and devices that will be paid separately in the HOPD and ASC settings beginning in CY 2026.” 5. Practice Expense Methodology Updates (Physician Fee Schedule) “CMS is finalizing significant updates to the practice expense methodology.” “CMS is finalizing changes to recognize greater indirect costs for practitioners in office-based settings compared to facility settings.” “CMS stated that allocating indirect costs at the same rate across settings may no longer reflect contemporary clinical practice patterns.” References and Source Documents: The following are the official CMS and Federal Register documents that form the policy framework referenced in this article. These are the appropriate sources to cite or link for verification. CMS Final Rules and Fact Sheets
CMS Implementation and Program Guidance
Federal Register
Primary CMS & Federal Register URLs (CY 2026) 1. CY 2026 Medicare Physician Fee Schedule (PFS) – Final RuleCMS Fact Sheet (Summary)CMS CY 2026 PFS Final Rule Fact Sheet https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-medicare-physician-fee-schedule-final-rule-cms-1832-f This page summarizes:
Federal Register Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes https://www.federalregister.gov/documents/2025/11/05/2025-19787/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other-changes This is the official regulatory text for CMS-1832-F. 2. CY 2026 OPPS & ASC – Final Rule CMS Fact Sheet (Summary) CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Final Rule https://www.cms.gov/newsroom/fact-sheets/calendar-year-2026-hospital-outpatient-prospective-payment-system-opps-ambulatory-surgical-center This page covers:
Federal Register Medicare Program; Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System and Quality Reporting Programs; CY 2026 Final Rule https://www.federalregister.gov/documents/2025/11/25/2025-20907/medicare-program-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center-payment-system-and-quality-reporting-programs 3. CMS Non-Opioid Pain Relief Payment Guidance CMS Implementation Guidance Non-Opioid Pain Management – Quarterly Implementation Process https://www.cms.gov/medicare/payment/fee-for-service-providers/opps/non-opioid-pain-management This CMS page supports:
4. CMS ASC Covered Procedures List (CPL) CMS Reference Page Ambulatory Surgical Center (ASC) Payment – Covered Procedures https://www.cms.gov/medicare/payment/fee-for-service-providers/ascpayment/asc-covered-procedures This page links to:
5. CMS General OPPS & ASC Payment Framework CMS Program Overview Hospital Outpatient Prospective Payment System (OPPS) https://www.cms.gov/medicare/payment/fee-for-service-providers/hospital-outpatient-prospective-payment-system Useful for:
About the Author:
Pinky Maniri-Pescasio is a healthcare operations and reimbursement consultant with more than two decades of experience supporting U.S. medical practices, with a primary focus on pain management and orthopedic specialties. She is the Founder and CEO of GoHealthcare Practice Solutions, where she advises physician groups, ambulatory surgery centers, and healthcare organizations on Medicare compliance, revenue cycle integrity, payer policy alignment, and operational risk management. Her work centers on interpreting and operationalizing CMS payment policy, including the Medicare Physician Fee Schedule, OPPS and ASC payment systems, and payer site-of-service requirements. She regularly works with practices navigating outpatient migration, prior authorization alignment, reimbursement variability by setting, and audit preparedness. Pinky’s perspective is grounded in direct industry experience rather than theoretical analysis. Her work emphasizes accuracy, regulatory alignment, and practical application of CMS guidance, particularly as it affects high-utilization procedural specialties. She is known for translating complex CMS policy into clear operational implications without overstating regulatory intent or introducing unnecessary risk. WISeR Is Here What the CMS WISeR Model Means for Pain Management Practices and Epidural Steroid Injections The Centers for Medicare and Medicaid Services has implemented the Wasteful and Inappropriate Service Reduction Model known as WISeR. This model directly affects pain management practices, particularly those performing epidural steroid injections for Original Medicare beneficiaries. WISeR focuses on medical necessity, documentation quality, and utilization patterns. Under this model, selected services, including epidural steroid injections, are subject to prior authorization or enhanced pre-payment medical review. This review occurs before reimbursement, not after. Pain management practices in the six affected states must now align closely with Local Coverage Determinations. These LCDs govern what Medicare considers reasonable and necessary for epidural steroid injections. The affected states are:
Section 1 Why Pain Management Is Central to WISeR Epidural steroid injections have long been among the most scrutinized pain management procedures in Medicare due to:
Section 2 How WISeR Applies to Epidural Steroid Injections Pain management practices in WISeR states performing epidural steroid injections must follow one of two review pathways:
Section 3 Documentation Expectations Under WISeR for Epidural Steroid Injections Pain management practices must ensure the following are documented clearly and consistently: 1 Diagnosis linked to symptoms Radicular pain or spinal stenosis must correlate with the spinal level being treated. 2 Imaging correlation MRI or CT findings must support the injection level and laterality. 3 Conservative treatment history LCDs require documentation of attempted non procedural treatment before an epidural injection. 4 Functional impairment Document measurable limitations such as: • Oswestry • PROMIS • Numeric Rating Scale • PEG • ADL restrictions 5 Response to prior injections If the patient had earlier injections, the record must document meaningful functional improvement. 6 Frequency and timing LCDs limit the number of epidural injections per spinal region within defined timeframes. 7 Procedural technique Documentation must identify the approach such as: • Interlaminar • Transforaminal • Caudal and include spinal level and laterality. Section 4 LCD Expectations for Each WISeR State The six WISeR states fall under three Medicare Administrative Contractors. Although each LCD is slightly different, all require imaging correlation, conservative care, functional assessment, and response to prior treatment. New Jersey MAC: Novitas Solutions Key LCD elements:
Ohio MAC: CGS Administrators Key LCD elements:
Oklahoma MAC: Noridian Healthcare Solutions Key LCD elements:
Texas MAC: Novitas Solutions Similar to New Jersey:
Arizona MAC: Noridian Healthcare Solutions Key LCD elements:
Washington MAC: Noridian Healthcare Solutions Key LCD elements:
Section 5 Site of Service Considerations WISeR brings elevated scrutiny to office-based interventional pain procedures. For epidural injections performed in the office, documentation should support:
Section 6 Operational Adjustments Required Under WISeR Pain management practices should implement:
Section 7 Financial Impact on Pain Management Practices Pain practices will encounter:
Section 8 What Pain Management Practices Must Do Now Pain management practices in the WISeR states should:
Takeaways: WISeR marks a new era in Medicare oversight for pain management. Epidural steroid injections now require strict LCD compliance at the point of care, not months later during an audit. Pain management practices that prepare now will maintain patient access, avoid unnecessary denials, and operate with confidence in the WISeR environment. LCD and WISeR References:
LCDs for Epidural Steroid Injections (WISeR States): Novitas Solutions (New Jersey and Texas) Local Coverage Determination for Epidural Steroid Injections https://www.novitas-solutions.com CGS Administrators (Ohio) Local Coverage Determination for Epidural Steroid Injections https://www.cgsmedicare.com Noridian Healthcare Solutions (Oklahoma, Arizona, Washington)Local Coverage Determination for Epidural Steroid Injections https://med.noridianmedicare.com About the Author:
Pinky Maniri-Pescasio is the Founder and Chief Executive Officer of GoHealthcare Practice Solutions, a nationally recognized healthcare consulting and revenue cycle management organization serving physician practices, surgery centers, and healthcare organizations across the United States. With more than two decades of experience in healthcare operations, billing, coding, compliance, and Medicare policy, Pinky is a recognized expert in prior authorization and utilization management, consistently achieving a documented success rate exceeding 98 percent. Her work is focused on helping healthcare organizations navigate complex regulatory requirements while protecting revenue integrity and patient access. Pinky is widely known for translating complex CMS regulations into practical, executable workflows for physicians, administrators, and revenue cycle leaders. She works closely with clinical and operational teams to align medical necessity documentation, coverage requirements, and utilization management strategies to reduce denials and strengthen long-term compliance. As Medicare continues to shift toward proactive oversight models such as WISeR, Pinky’s guidance emphasizes preparation, documentation excellence, and operational discipline. Her perspective is grounded in real-world implementation experience rather than theory, making her a trusted advisor to organizations adapting to evolving CMS expectations. What Is the CMS WISeR Model? Prior Authorization Rules, States Affected, and Provider Responsibilities What Is the CMS WISeR Model? Prior Authorization Rules, States Affected, and Provider ResponsibilitiesBeginning January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) launches one of the most significant utilization management reforms in the history of Traditional Medicare — the Wasteful and Inappropriate Services Reduction (WISeR) Model. For the first time, CMS will apply systematic prior authorization requirements to selected Medicare Part B services in six U.S. states:
This article provides a full executive breakdown of what WISeR is, why CMS is implementing it, what providers must prepare for, and how POS 11 becomes a high-risk category under this new model. Section 1: Understanding the WISeR Model 1.1 What Is WISeR? WISeR — Wasteful and Inappropriate Services Reduction is a CMS Innovation Center model designed to:
Unlike previous programs, WISeR introduces mandatory prior authorization requirements for selected high-risk services in Traditional Medicare. This shift heavily affects specialties such as:
1.2 Why CMS Created WISeR CMS built WISeR in response to patterns found in fee-for-service Medicare:
Section 2: The Six WISeR States and Why They Were Selected CMS chose six states to represent diverse Medicare environments: 1. New Jersey — advanced utilization markets and complex urban populations 2. Ohio — large mix of aging and chronic disease cohorts 3. Oklahoma — high procedural utilization in certain specialties 4. Texas — one of the largest Medicare populations in the U.S. 5. Arizona — rapidly growing population and interventional service expansion 6. Washington — significant rural-urban variation in service utilization These states were selected to evaluate whether prior authorization:
Section 3: WISeR and Prior Authorization. A New Compliance Era WISeR Introduces Mandatory Prior Authorization For Traditional Medicare providers, this is a historic shift. No prior authorization = claim denial or pre-payment review. 3.2 Increased Administrative and Documentation Requirements WISeR requires:
Section 4: Place of Service 11 (Office) A WISeR High-Risk Category Under WISeR Place of Service 11 is no longer just a billing detail; it is a compliance signal. 4.1 What Is POS 11? POS 11 represents medical services furnished in a physician’s office, which:
4.2 Why CMS Is Targeting POS 11 CMS has seen concerning patterns in office-based procedures:
CMS reviewers will expect:
Section 5: Documentation Standards Under WISeR For any service requiring prior authorization, especially in POS 11 CMS expects: A. Diagnosis-to-Procedure Alignment Every element of the diagnosis must clearly justify the chosen procedure. B. Imaging Requirements MRI, CT, X-ray, or diagnostic testing must show pathology supporting intervention. C. Failed Conservative Treatment Documented therapies such as PT, medications, chiropractic care, or behavioral interventions. D. Functional Impairment Metrics Use of nationally recognized scales such as:
CMS LCDs outline:
F. Provider Clinical Notes Detailed HPI, ROS, examination findings, risk-benefit documentation. Section 6: Provider Responsibilities and Operational Readiness 6.1 Build a WISeR Compliance Infrastructure Practices must develop:
6.2 Training Providers on WISeR Documentation Physicians must be trained on:
Section 7: Financial Impact Under WISeR WISeR will influence revenue cycles in several ways: 1. Increased pre-service workload More administrative tasks for prior authorization. 2. Cash flow delays Claims may be placed on pre-payment review. 3. Higher denial rates Especially for poorly documented POS 11 procedures. 4. Increased need for staffing or outsourcing RCM teams will need more manpower or external support. 5. Greater reliance on AI for documentation improvement To meet WISeR documentation standards at scale. Section 8: The Future — WISeR Will Expand Based on CMS intent and historical patterns, WISeR is set to:
Section 9: What Providers Must Do Now Practices in the six WISeR states New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington must immediately:
WISeR Is the New Compliance Landscape. Especially for POS 11 The CMS WISeR Model signals a new compliance era where:
Clinics that build strong RCM infrastructure, documentation excellence, and POS 11 compliance will not only survive WISeR they will thrive under it. REFERENCES & SOURCES: Centers for Medicare & Medicaid Services. (2025). WISeR Model: Wasteful and Inappropriate Service Reduction Model. https://www.cms.gov/priorities/innovation/innovation-models/wiser Centers for Medicare & Medicaid Services. (2025). WISeR Model: Frequently Asked Questions. https://www.cms.gov/priorities/innovation/files/document/wiser-model-frequently-asked-questions Centers for Medicare & Medicaid Services. (2025). WISeR Model Provider and Supplier Operational Guide [PDF]. https://www.cms.gov/priorities/innovation/files/wiser-provider-supplier-guide.pdf Centers for Medicare & Medicaid Services. (2025). CMS launches new model targeting wasteful, inappropriate services in Original Medicare [Press release]. https://www.cms.gov/newsroom/press-releases/cms-launches-new-model-target-wasteful-inappropriate-services-original-medicare Moss Adams. (2026). Medicare WISeR Model. https://www.mossadams.com/articles/2026/01/medicare-wiser-model ElderLawAnswers. (2025). Six states to pilot prior authorizations for Original Medicare. https://www.elderlawanswers.com/6-states-to-pilot-prior-authorizations-for-original-medicare-21225 STAT News. (2025). Medicare WISeR prior authorization pilot brings tech vendors into oversight. https://www.statnews.com/2025/11/06/medicare-wiser-prior-authorization-pilot-tech-vendors/ Pinky Maniri-Pescasio is the CEO and Founder of GoHealthcare Practice Solutions, a nationally recognized medical practice consulting and revenue cycle management organization specializing in CMS compliance, prior authorization strategy, Medicare audit defense, and operational governance for high-acuity specialties. About the Author:
Pinky Maniri-Pescasio is the CEO and Founder of GoHealthcare Practice Solutions, a nationally recognized medical practice consulting and revenue cycle management organization specializing in CMS compliance, prior authorization strategy, Medicare audit defense, and operational governance for high-acuity specialties. With over 28 years of experience in healthcare operations, Pinky has advised pain management, spine, orthopedic, neurology, and multi-specialty practices across the United States on navigating complex reimbursement models, Local Coverage Determinations (LCDs), utilization management, and documentation integrity. Her work sits at the intersection of clinical operations, regulatory compliance, and financial sustainability. Pinky is widely regarded as an authority on CMS policy interpretation, prior authorization workflows, and Traditional Medicare compliance, with a particular focus on emerging models such as WISeR (Wasteful and Inappropriate Services Reduction). She is also a leader in AI governance in healthcare, helping organizations deploy technology responsibly while maintaining audit readiness and patient access. As a frequent speaker, strategist, and advisor, Pinky is known for translating complex CMS regulations into clear, actionable frameworks that protect revenue, ensure compliance, and support high-quality patient care. |
Pinky Maniri-Pescasio
Founder and CEO of GoHealthcare Practice Solutions. She is after-sought National Speaker in Healthcare. She speaks at select medical conferences and association events including at Beckers' Healthcare and PainWeek.
Pinky Maniri-Pescasio, MSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in A.I. Governance is a nationally recognized leader in Revenue Cycle Management, Utilization Management, and Healthcare AI Governance with over 28 years of experience navigating Medicare, CMS regulations, and payer strategies. As the founder of GoHealthcare Practice Solutions, LLC, she partners with pain management practices, ASCs, and specialty groups across the U.S. to optimize reimbursement, strengthen compliance, and lead transformative revenue cycle operations. Known for her 98% approval rate in prior authorizations and deep command of clinical documentation standards, Pinky is also a Certified Specialist in Healthcare AI Governance and a trusted voice on CMS innovation models, value-based care, and policy trends. She regularly speaks at national conferences, including PAINWeek and OMA, and works closely with physicians, CFOs, and administrators to future-proof their practices. Current HFMA Professional Expertise Credentials: HFMA Certified Specialist in Physician Practice Management (CSPPM) HFMA Certified Specialist in Revenue Cycle Management (CRCR) HFMA Certified Specialist Payment & Reimbursement (CSPR) HFMA Certified Specialist in Business Intelligence (CSBI) search hereArchives
January 2026
Categories
All
BROWSE HERE
All
|

RSS Feed